BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36826759)

  • 1. Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma.
    Tsukamoto T; Miki Y
    Jpn J Radiol; 2023 Aug; 41(8):789-806. PubMed ID: 36826759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 2. Neoplasms other than PitNET and tumor-mimicking lesions.
    Tsukamoto T; Miki Y
    Jpn J Radiol; 2023 Aug; 41(8):808-829. PubMed ID: 36913010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine Tumors: Clinical Practices, Controversies, and Perspectives.
    Wan XY; Chen J; Wang JW; Liu YC; Shu K; Lei T
    Curr Med Sci; 2022 Dec; 42(6):1111-1118. PubMed ID: 36544040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal.
    Villa C; Baussart B; Assié G; Raverot G; Roncaroli F
    Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37068095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overview of the New World Health Organization Classification of Pituitary Neuroendocrine Tumors].
    Kurosaki M
    No Shinkei Geka; 2023 Sep; 51(5):910-916. PubMed ID: 37743343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer Concepts in the Classification of Pituitary Adenomas.
    Sathyakumar R; Chacko G
    Neurol India; 2020; 68(Supplement):S7-S12. PubMed ID: 32611886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.
    Lopes MBS
    Acta Neuropathol; 2017 Oct; 134(4):521-535. PubMed ID: 28821944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
    Xie J; Wu ZB
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.
    Mete O; Wenig BM
    Head Neck Pathol; 2022 Mar; 16(1):123-142. PubMed ID: 35312985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?
    Lee CH
    Brain Tumor Res Treat; 2023 Jul; 11(3):173-176. PubMed ID: 37550816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [WHO Histological Classification of Pituitary Tumors].
    Nishioka H
    No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
    Dottermusch M; Schüller U; Hagel C; Saeger W
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular biology of thyrotroph pituitary neuroendocrine tumors.
    Horiguchi K
    Endocr J; 2023 Feb; 70(2):135-139. PubMed ID: 36653153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.
    Asa SL; Casar-Borota O; Chanson P; Delgrange E; Earls P; Ezzat S; Grossman A; Ikeda H; Inoshita N; Karavitaki N; Korbonits M; Laws ER; Lopes MB; Maartens N; McCutcheon IE; Mete O; Nishioka H; Raverot G; Roncaroli F; Saeger W; Syro LV; Vasiljevic A; Villa C; Wierinckx A; Trouillas J;
    Endocr Relat Cancer; 2017 Apr; 24(4):C5-C8. PubMed ID: 28264912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenomas - practical approach to the diagnosis and the changes in the 2017 WHO classification.
    Rychlý B; Puchertová M; Švajdler M; Zámečník J
    Cesk Patol; 2019; 55(3):137-144. PubMed ID: 31726839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and controversies in the classification and grading of pituitary tumors.
    Laws ER; Penn DL; Repetti CS
    J Endocrinol Invest; 2019 Feb; 42(2):129-135. PubMed ID: 29858984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower
    Tjörnstrand A; Casar-Borota O; Heurling K; Schöll M; Gjertsson P; Himmelman J; Itsenko O; Ragnarsson O; Filipsson Nyström H
    Clin Endocrinol (Oxf); 2020 Mar; 92(3):222-231. PubMed ID: 31868239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.